WOLFF-PARKINSON-WHITE SYNDROME

Clinical trials for WOLFF-PARKINSON-WHITE SYNDROME explained in plain language.

Never miss a new study

Get alerted when new WOLFF-PARKINSON-WHITE SYNDROME trials appear

Sign up with your email to follow new studies for WOLFF-PARKINSON-WHITE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Can a Gene-Silencing drug tame a rare heart disease?

Disease control Not yet recruiting

This trial tests an investigational medicine called ATR 1072 in adults with PRKAG2 syndrome, a genetic condition that causes abnormal heart muscle thickening and rhythm problems. The drug is designed to reduce the activity of the faulty PRKAG2 gene. Researchers are evaluating its…

Matched conditions: WOLFF-PARKINSON-WHITE SYNDROME

Phase: PHASE1, PHASE2 • Sponsor: Atrium Therapeutics • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

WOLFF-PARKINSON-WHITE SYNDROME

Get alerted when new WOLFF-PARKINSON-WHITE SYNDROME trials appear

Can a Gene-Silencing drug tame a rare heart disease?